VIỆN NGHIÊN CỨU ỨNG DỤNG CÔNG NGHỆ TẾ BÀO 幹細胞応用研究所
0866022097

BÁO CÁO KHOA HỌC QUỐC TẾ

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
REVIEW published: 31 May 2021 doi: 10.3389/fmed.2021.655268 The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues Ya Yang† | Yalei Zhao† | Lingjian Zhang | Fen Zhang and Lanjuan Li* State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute-on-Chronic Liver Failure Patients
TISSUE-SPECIFIC PROGENITOR AND STEM CELLS Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute-on-Chronic Liver Failure Patients MING SHI, ZHENG ZHANG, RUONAN XU, HU LIN, JUNLIANG FU, ZHENGSHENG ZOU, AIMIN ZHANG, JIANFEI SHI, LIMING CHEN, SA LV, WEIPING HE, HUA GENG, LEI JIN, ZHENWEN LIU, FU-SHENG WANG Key Words: Clinical trials • Stem cell transplantation • Umbilical cord • Liver
Tiềm năng của tế bào gốc trung mô trong điều trị bệnh lý gan
Tiềm năng của tế bào gốc trung mô trong điều trị bệnh lý gan The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues (2021) The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials (2022)
Use of mesenchymal stem cells for chronic kidney disease
Editorial Kidney Res Clin Pract 2019;38(2):131-134 pISSN: 2211-9132 • eISSN: 2211-9140 https://doi.org/10.23876/j.krcp.19.051 Use of mesenchymal stem cells for chronic kidney disease Byung Ha Chung Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
TYPE Review PUBLISHED 04 October 2022 DOI 10.3389/fcell.2022.910592 Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease Jiali Wang, Yongda Lin, Xiutian Chen, Yiping Liu and Tianbiao Zhou* Department of Nephrology, the Second Affiliated Hospital, Shantou University Medical College, Shantou, China
Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility
Original Article Kidney Res Clin Pract 2019;38(2):176-185 pISSN: 2211-9132 • eISSN: 2211-9140 https://doi.org/10.23876/j.krcp.18.0139 Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility Sandra Villanueva1 , Fernando González2 , Eduardo Lorca2 , Andrés Tapia3 , Valentina López G4 , Rocío Strodthoff1 , Francisca Fajre1 , Juan E. Carreño1 , Ricardo Valjalo2 , César Vergara1 , Manuel Lecanda1 , Jorge Bartolucci4 , Fernando E. Figueroa3,5,6,* , Maroun Khoury3,4,5,* Laboratory of Molecular and Integrative Physiology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile Department of Nephrology, Hospital Salvador, Santiago, Chile Laboratory of Nano-regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile Cells for Cells, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile Program for Translational Research in Cell Therapy and Consorcio Regenero, the Chilean Consortium for Regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Tế bào gốc trung mô – liệu pháp mới cho bệnh thận mạn tính (CKD – chronic kidney disease)
Tế bào gốc trung mô – liệu pháp mới cho bệnh thận mạn tính (CKD – chronic kidney disease) Frontiers | Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease (frontiersin.org) (2022) Use of mesenchymal stem cells for chronic kidney disease (krcp-ksn.org) (2019)
Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efcacy
Centeno et al. J Transl Med (2017) 15:197 DOI 10.1186/s12967-017-1300-y Journal of Translational Medicine RESEARCH | Open Access Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efcacy Christopher Centeno1,2 | Jason Markle1 | Ehren Dodson2* | Ian Stemper2 | Christopher J. Williams1 | Matthew Hyzy1 | Thomas Ichim3 | Michael Freeman4
Stem Cells and Intervertebral Disc Regeneration Overview—What They Can and Can’t Do
International Journal of Spine Surgery, Vol. 15, Supplement 1, 2021, pp. S40–S53 https://doi.org/10.14444/8054 International Society for the Advancement of Spine Surgery Stem Cells and Intervertebral Disc Regeneration Overview—What They Can and Can’t Do GIANLUCA VADALA, MD, PHD, LUCA AMBROSIO, MD, FABRIZIO RUSSO, MD, ROCCO PAPALIA, MD, PHD, VINCENZO DENARO, MD Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy
Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study
CLINICAL AND TRANSLATIONAL RESEARCH Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study Lluis Orozco, Robert Soler, Carles Morera, Mercedes Alberca, Ana Sa ́nchez, and Javier García-Sancho

Đăng ký nhận tin 情報を受け取るために購読する